Global Biomaterial Market (2010 - 2015)
Report Description:
The global market for biomaterials is expected to reach $64.7 billion in 2015 from $25.6 billion in 2008 with a CAGR of 15% from 2010 to 2015. In 2010, the orthopedic biomaterial market recorded revenues of $12 billion or 37.5% of the total global biomaterial market. This is mainly because of the demand generated by the increasing aging population worldwide, and introduction of sophisticated technologies in the biomaterials market. However, the orthopedic biomaterials market is estimated to grow slowly, at a CAGR of 12.7% (2010 to 2015) because the market is relatively mature compared to other product markets. Cardiovascular biomaterial is the second-highest market, and contributed 36.1% to the global biomaterial market in 2010.
With the increase in the percentage of aging population worldwide, the number of individuals suffering from physical disability is also increasing. Baby boomers born between the years 1946 and 1964 are the major consumers of the biomaterial products. Also, more than 20% of the global population is expected to be over 60 years in 2050 and this segment of the population will be significantly high in developing countries. This increase in the aging population will drive the demand for biomaterial products.
The biomaterial market definitely holds a significant opportunity for innovators, but extensive research is required to develop new and improved products at competitive prices. Particularly in the developing countries pricing is a major deciding factor for the biomaterial markets. The other issue involves regulations that have to be streamlined. This will open more doors for the development of new and improved products, new opportunities in terms of application areas and eventually increase the market size for the products. Biomaterial products are expensive, and an improvement in performance would justify the higher pricing and also boost the market size. Major developments in the biomaterials market will be witnessed with the cooperation between the material suppliers and manufacturing companies; thus streamlining mergers and acquisitions would help the overall market. The U.S. government is expected to spend more in the medical care sector; that, in turn, could boost the market for biomaterials provided the economy revives. The effect of the current economic downturn is also felt by the companies manufacturing biomaterial products because although these companies are compensated by the health insurers, patients have delayed their scheduled procedures. However, the effect of the poor state of the economy influencing the timing of surgeries is expected to wane gradually. When that happens, companies into the biomaterials market will enjoy higher demand, leading to higher revenues.
Markets Covered
This research report categorizes the biomaterials market into the following:
Stakeholders
The targeted audience for this report includes:
Secondary research is carried out using proprietary databases (both paid and public), company websites, news articles, etc. The primary research involves interviews with specialists, CEO’s, managers, and directors working with major market players (key industry participants) and subject matter experts from research institutes. Data and analytic output from secondary research such as markets drivers, restraints, growth opportunities, market forecasts, and others have been validated with primary research. Market size of the segments was calculated using the bottom-up approach and figures thus derived were added to yield the biomaterial market revenues, while each year’s forecast is based on the analysis of industry trends.
The primary research involves interviews with specialists, CEO’s, managers, and directors from major market players (key industry participants) and subject matter experts from research institutes. Data & analytic output from secondary research such as markets drivers, restraints, growth opportunities, market forecasts, and others were validated with the primary research.
Hence, market size of the segments was calculated using bottom-up approach and figures thus derived were added to yield the biomaterial market revenues; while each year’s forecast is based on industry trend analysis
The global market for biomaterials is expected to reach $64.7 billion in 2015 from $25.6 billion in 2008 with a CAGR of 15% from 2010 to 2015. In 2010, the orthopedic biomaterial market recorded revenues of $12 billion or 37.5% of the total global biomaterial market. This is mainly because of the demand generated by the increasing aging population worldwide, and introduction of sophisticated technologies in the biomaterials market. However, the orthopedic biomaterials market is estimated to grow slowly, at a CAGR of 12.7% (2010 to 2015) because the market is relatively mature compared to other product markets. Cardiovascular biomaterial is the second-highest market, and contributed 36.1% to the global biomaterial market in 2010.
With the increase in the percentage of aging population worldwide, the number of individuals suffering from physical disability is also increasing. Baby boomers born between the years 1946 and 1964 are the major consumers of the biomaterial products. Also, more than 20% of the global population is expected to be over 60 years in 2050 and this segment of the population will be significantly high in developing countries. This increase in the aging population will drive the demand for biomaterial products.
The biomaterial market definitely holds a significant opportunity for innovators, but extensive research is required to develop new and improved products at competitive prices. Particularly in the developing countries pricing is a major deciding factor for the biomaterial markets. The other issue involves regulations that have to be streamlined. This will open more doors for the development of new and improved products, new opportunities in terms of application areas and eventually increase the market size for the products. Biomaterial products are expensive, and an improvement in performance would justify the higher pricing and also boost the market size. Major developments in the biomaterials market will be witnessed with the cooperation between the material suppliers and manufacturing companies; thus streamlining mergers and acquisitions would help the overall market. The U.S. government is expected to spend more in the medical care sector; that, in turn, could boost the market for biomaterials provided the economy revives. The effect of the current economic downturn is also felt by the companies manufacturing biomaterial products because although these companies are compensated by the health insurers, patients have delayed their scheduled procedures. However, the effect of the poor state of the economy influencing the timing of surgeries is expected to wane gradually. When that happens, companies into the biomaterials market will enjoy higher demand, leading to higher revenues.
Markets Covered
This research report categorizes the biomaterials market into the following:
- Biomaterial market, by products: Orthopedic, cardiovascular, wound care, gastrointestinal, urological, plastic surgery, and others
- Biomaterial market, by materials: Metals, polymers, ceramics, and composites
- Biomaterial market, by application: General surgery, surgical appliances and supplies, surgical and medical instruments, dental products, electro medical equipment, and other applications
- The report provides market estimates and forecasts for the global biomaterial market. In addition to market sizing and forecasts, the report offers a detailed analysis of the market trends, opportunities, and the factors influencing the growth of each segment of the biomaterials market. The report also draws a competitive landscape, analyzing core competencies of major players and strategies adopted to expand their market presence.
Stakeholders
The targeted audience for this report includes:
- Pharmaceutical and biotech companies
- Medical devices manufacturers
- Pharma-research labs
- Doctors, physicians, and hospitals
- Medical/Pharma associations
- Retailers and super-retailers
- Technology providers
- Research and development (R&D) companies
- Research methodology
Secondary research is carried out using proprietary databases (both paid and public), company websites, news articles, etc. The primary research involves interviews with specialists, CEO’s, managers, and directors working with major market players (key industry participants) and subject matter experts from research institutes. Data and analytic output from secondary research such as markets drivers, restraints, growth opportunities, market forecasts, and others have been validated with primary research. Market size of the segments was calculated using the bottom-up approach and figures thus derived were added to yield the biomaterial market revenues, while each year’s forecast is based on the analysis of industry trends.
The primary research involves interviews with specialists, CEO’s, managers, and directors from major market players (key industry participants) and subject matter experts from research institutes. Data & analytic output from secondary research such as markets drivers, restraints, growth opportunities, market forecasts, and others were validated with the primary research.
Hence, market size of the segments was calculated using bottom-up approach and figures thus derived were added to yield the biomaterial market revenues; while each year’s forecast is based on industry trend analysis
1. INTRODUCTION
1.1. KEY TAKE-AWAYS
1.2. MARKET COVERED
1.3. REPORT DESCRIPTION
1.4. STAKEHOLDERS
2. SUMMARY
3. MARKET OVERVIEW
3.1. DRIVING FACTOR ANALYSIS OF GLOBAL BIOMATERIAL MARKET
3.1.1. SUPPLY SIDE DRIVERS
3.1.2 DEMAND SIDE DRIVERS
3.1.3. RESTRAINTS
3.1.4. OPPORTUNITIES
3.1.5. KEY COMPETITIVE POINTS
3.2. DEFINING THE GLOBAL BIOMATERIAL MARKET
3.3. DEFINING THE BIOMATERIAL DEVICE MARKET
3.4. DRIVERS
3.4.1. NEW AND IMPROVED TECHNOLOGIES
3.4.2. DEVELOPMENTS IN BIOCOMPATIBILITY SCIENCE
3.4.3. LARGE APPLICATION AREA
3.4.4 INTRODUCTION OF BIO-ABSORBABLE BIOMATERIALS
3.4.5. RISING AWARENESS
3.4.6 MEDICAL APPLICATIONS OF SYNTHETIC BIOMATERIALS
3.4.7. BIOMATERIALS HELP TREAT AGE-RELATED PROBLEMS
3.4.8. MEDICAL INSURANCE COVERAGE
3.4.9. RECENT DEVELOPMENTS IN BIOMATERIAL RESEARCH
3.4.10. INCREASING FOCUS ON PERSONAL HEALTHCARE
3.5. INHIBITORS
3.5.1. LACK OF TISSUE AVAILABILITY
3.5.2. LACK OF PROPER REIMBURSEMENT FACILITIES
3.6. OPPORTUNITIES
3.6.1. MARKET PARTICIPATION BY SMALLER COMPANIES
3.6.2. GROWING NEED FOR INTEGRATED AND COMBINED MATERIALS
3.6.3. INTELLIGENT MATERIALS WITH DYNAMIC MOLECULAR FUNCTIONS
3.6.4. EMERGING PREFERENCE FOR MINIMALLY INVASIVE SURGERY
4. BIOMATERIAL PRODUCT MARKET
4.1. ORTHOPEDIC BIOMATERIALS
4.1.1. DRIVERS
4.1.1.1. Product penetration
4.1.1.2. Increasing use of orthopedic biomaterials in spine surgery
4.1.1.3. Easy surgical procedures
4.1.2. INHIBITORS
4.1.2.1. Economic constraints
4.1.2.2. Increasing competition lessens profit margin
4.1.3. OPPORTUNITIES
4.1.3.1. Spinal treatment expected to be on the rise
4.1.4. TOP PLAYER ANALYSIS OF ORTHOPEDIC BIOMATERIAL MARKET
4.1.5. RTHOPEDIC RECONSTRUCTIVE BIOMATERIALS
4.1.5.1. Drivers
4.1.5.1.1. Wide range of products available for specific applications
4.1.5.1.2. Development of new materials with improved properties
4.1.5.2. Market inhibitors and opportunities
4.1.5.3. Top Players analysis in Orthopedic Reconstructive market
4.1.5.4. Artificial hip biomaterial market
4.1.5.4.1. Cemented prostheses biomaterial market
4.1.5.4.2. Uncemented prostheses biomaterial market
4.1.5.5. Artificial knee biomaterial market
4.1.5.5.1. Non-constraint implants
4.1.5.5.2. Semi-constraint implants
4.1.5.5.3. Constraint implants
4.1.6. TRAUMA BIOMATERIALS
4.1.6.1. Drivers
4.1.6.1.1. Sports injuries and other accidents
4.1.6.1.2. Plate and screw systems spur overall market growth
4.1.6.2. Top Players Analysis of Trauma Orthopedic Biomaterial Market
4.1.7. ORTHOBIOLOGIC BIOMATERIALS 56
4.1.7.1. Top player analysis of orthobiologics biomaterial market
4.1.7.2. DBM
4.1.7.3. Machined bone allografts
4.1.7.4. Non-proprietary allografts
4.1.7.5. Synthetic bone substitute
4.1.7.6. Bone morphogenic protein (BMP)
4.1.7.7. Platelet concentrates
4.1.8. SPORTS MEDICINE BIOMATERIALS
4.1.8.1. Market Drivers
4.1.8.2. Top player analysis of sports medicine orthopedic biomaterial market
4.1.9. BONE CEMENT
4.1.9.1. Market Drivers
4.1.9.1.1. Bone cements ease lesions and can be used with antibiotics
4.1.9.2. Inhibitors and opportunities
4.1.9.3. Top player analysis of bone cement orthopedic biomaterial market
4.1.10.SPINAL BIOMATERIALS
4.1.10.1.Drivers
4.1.10.1.1. Spinal treatment for younger patients on the rise
4.1.10.1.2. Motio- preserving devices drive growth
4.1.10.2.Inhibitors & Opportunities
4.1.10.2.1. Reimbursement challenges restrain growth
4.1.10.2.2. Technology and product development will provide scope for improvement
4.1.10.3.Top player analysis of spine orthopedic biomaterial market
4.1.10.4.Cervical Biomaterials
4.1.10.5.Lumbar Biomaterials
4.1.11.DENTAL BIOMATERIALS
4.1.11.1.Drivers
4.1.11.2.Inhibitors and opportunities
4.1.11.3.Top player analysis of dental orthopedic biomaterial market
4.1.11.4.Dental bone grafts and substitutes
4.1.11.5.Allograft
4.1.11.6.Xenograft
4.1.11.7.Synthetic dental bone graft and substitute market
4.1.11.8.Tissue regeneration
4.1.11.9.Dental membranes
4.2. CARDIOVASCULAR BIOMATERIALS
4.2.1. DRIVERS
4.2.1.1. Biomaterials enhance cardiovascular treatment
4.2.1.2. Rising number of obesity cases
4.2.1.3. Increase in thrombosis and heart failure treatments
4.2.1.4. Vascular surgery market is growing with the uses of biomaterials
4.2.2. INHIBITORS AND OPPORTUNITIES
4.2.3. TOP PLAYER ANALYSIS OF CARDIOVASCULAR BIOMATERIALS MARKET
4.2.4. CARDIAC PACEMAKERS BIOMATERIAL MARKET
4.2.4.1. Top player analysis of cardiac pacemaker cardiovascular biomaterial market
4.2.5. IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
4.2.5.1. Top player analysis of implantable cardioverter defibrillator cardiovascular biomaterial market
4.2.6. CARDIAC STENT
4.2.6.1. Top player analysis of cardiac stents biomaterial market
4.2.7. ARTIFICIAL HEART VALVES
4.2.7.1. Top player analysis of artificial heart valve cardiovascular biomaterial market
4.2.8. VASCULAR ACCESS DEVICES
4.2.8.1. Drivers & Inhibitors
4.2.8.2. Top player analysis of vascular access devices biomaterial market
4.2.9. PERIPHERAL VASCULAR GRAFTS
4.3. WOUND CARE BIOMATERIALS
4.3.1. DRIVERS
4.3.1.1. Multiple advantages over conventional wound care products
4.3.1.2. Supports healing process of the skin
4.3.1.3. Gel-based products accelerate wound healing
4.3.1.4. Prevention of bacterial colonization on sutures
4.3.1.5. Reduction in the cost of hospitalization
4.3.1.6. Eliminates frequent change of dressings
4.3.1.7. Increase in diabetes foot ulcer
4.3.2. INHIBITORS
4.3.2.1. Slow rate of product development
4.3.3. OPPORTUNITIES
4.3.3.1. Increase in penetration of negative pressure wound
4.3.3.2. Introduction of more efficient and cost effective therapies
4.3.3.3. Use of natural polymer biomaterials for stability in treatment
4.3.4. TOP PLAYER ANALYSIS OF WOUND CARE BIOMATERIAL MARKET
4.3.5. INTERNAL TISSUE SEALANT
4.3.5.1. Drivers
4.3.5.1.1. Technological advances
4.3.5.1.2. Wide range of applications and features
4.3.5.1.3. Faster healing
4.3.5.2. Top player analysis of internal tissue sealant wound care biomaterial market
4.3.5.3. Fibrin Sealants
4.3.5.4. Synthetic sealants
4.3.6. SURGICAL HEMOSTATS
4.3.6.1. Drivers
4.3.6.1.1. Surgical hemostats control bleeding
4.3.6.1.2. Reduces the need for frequent blood transfusions
4.3.6.2. Top player analysis of surgical hemostats market
4.3.6.3. Thrombin-based hemostats
4.3.6.4. Oxidized regenerated cellulose based topical hemostats
4.3.6.5. Gelatin-based hemostats
4.3.6.6. Combination hemostats
4.3.6.7. Collagen-based hemostats
4.3.6.8. Autologous-based hemostats
4.3.6.9. Polysaccharide-based hemostats
4.3.7. ADHESION BARRIERS
4.3.7.1. Drivers
4.3.7.2. Inhibitors and opportunities
4.3.7.3. Top player analysis of adhesion prevention wound care biomaterial market
4.3.7.4. Films
4.3.7.5. Gels
4.3.8. SKIN SUBSTITUTES
4.4. GASTROINTESTINAL BIOMATERIALS
4.4.1. DRIVERS
4.4.1.1. Increasing incidence of gastrointestinal diseases
4.4.1.2. FDA approval for OTC gastrointestinal drugs
4.4.2. INHIBITORS AND OPPORTUNITIES
4.4.3. TOP PLAYER ANALYSIS OF GASTROINTESTINAL BIOMATERIAL MARKET
4.5. UROLOGICAL BIOMATERIALS
4.5.1. DRIVERS
4.5.1.1. Availability of biodegradable materials for treatment
4.5.1.2. Development of scaffolds for the treatment of several disorders
4.5.2. INHIBITORS AND OPPORTUNITIES
4.5.3. TOP PLAYER ANALYSIS OF UROLOGICAL BIOMATERIAL MARKET
4.5.4. UROLOGICAL STENTS
4.5.4.1. Market Drivers
4.5.4.1.1. Stents are used in short duration treatment
4.5.4.1.2. Broad indications and growing population
4.5.4.2. Inhibitors and Opportunities
4.5.5. UROLOGICAL CATHETERS
4.5.5.1. Drivers & Inhibitors
4.5.5.1.1. Developments in catheter design have increased applicability
4.5.5.1.2. Prolonged use of catheters may lead to cancer
4.5.5.2. Opportunities
4.5.5.2.1. Use of biomaterials in catheters eliminates certain disadvantages
4.5.5.2.2. Biocompatibility of chemicals can be improved in catheters
4.5.5.3. Dialysis catheter
4.5.5.3.1. Top player analysis of dialysis catheter market
4.5.5.3.2. Hemodialysis catheter
4.5.5.3.3. Peritonial catheter
4.5.5.4. Urinary catheter
4.5.5.4.1. Indwelling catheter
4.5.5.4.2. External catheter
4.5.5.4.3. Intermittent catheter
4.6. PLASTIC SURGERY BIOMATERIALS
4.6.1. DRIVERS
4.6.1.1. Baby boomers to boost market growth
4.6.1.2. More surgeons are moving towards plastic surgery market from reconstructive procedures
4.6.1.3. Cultural factors boost the market growth
4.6.2. INHIBITORS & OPPORTUNITIES
4.6.2.1. Difficulties in treating craniofacial trauma
4.6.2.2. Male population untapped for facial surgeries
4.6.3. TOP PLAYER ANALYSIS OF PLASTIC SURGERY BIOMATERIAL MARKET
4.6.4. REAST IMPLANTS
4.6.4.1. Drivers
4.6.4.1.1. Availability of more refined procedures and wide range of choice
4.6.4.2. Inhibitors & opportunities
4.6.4.3. Top player analysis of breast implants biomaterial market
4.6.4.4. Saline-filled implants
4.6.4.5. Silicone-filled implants
4.6.5. INJECTABLE FILLERS
4.6.5.1. Drivers
4.6.5.1.1. Increase in awareness of skin care
4.6.5.1.2. Permanent results can be achieved using fillers
4.6.5.2. Inhibitors & opportunities
4.6.5.2.1. Allergy
4.6.5.3. Top player analysis of injectable fillers biomaterial market
4.6.6. FACIAL IMPLANTS
4.6.6.1. Drivers
4.6.6.1.1. Iraq war increased the demand for facial implants
4.6.6.1.2. Faster recovery and surgery times
4.6.6.2. Inhibitors and opportunities
4.6.6.3. Top player analysis of facial implants biomaterial market
4.7. OTHER BIOMATERIALS
5. BIOMATERIAL MARKET
5.1. CERAMICS
5.1.1. TOP PLAYER ANALYSIS OF CERAMICS BIOMATERIAL MARKET
5.1.2. BIOINERT CERAMICS
5.1.2.1. Drivers
5.1.2.1.1. Compatibility with high-strength applications
5.1.2.1.2. High chemical stability
5.1.2.2. Inhibitors and opportunities
5.1.2.3. Alumina
5.1.2.4. Zirconia ceramic
5.1.2.5. Other bioinert ceramics market
5.1.3. BIOACTIVE CERAMICS
5.1.3.1. Drivers
5.1.3.1.1. Ceramics aid bone formation
5.1.3.2. Inhibitors and Opportunities
5.1.3.3. Bioglass
5.1.3.4. Other bioactive ceramics market
5.1.4. BIODEGRADABLE CERAMICS
5.1.4.1. Hydroxyapetite
5.1.4.2. Others biodegradable biomaterial market
5.2. BIOMATERIAL METALS
5.2.1. DRIVERS
5.2.1.1. Balancing act of metallic biomaterials
5.2.1.2. Improved properties of metallic biomaterials
5.2.2. INHIBITORS
5.2.2.1. Corrosion may occur in the implant
5.2.3. OPPORTUNITIES
5.2.3.1. Improvement in corrosion resistance
5.2.3.2. Introduction of new alloys
5.2.4. TOP PLAYER ANALYSIS OF METALLIC BIOMATERIAL MARKET
5.2.5. PURE FORM METALS
5.2.5.1. Titanium
5.2.5.2. Gold
5.2.5.3. Silver
5.2.5.4. Platinum
5.2.6. ALLOYS
5.2.6.1. Drivers
5.2.6.1.1. Can be sterilized easily
5.2.6.2. Inhibitors and opportunities
5.2.6.3. Top player analysis of alloy biomaterial market
5.2.6.4. High Carbon Cobalt Chromium Alloy
5.3. POLYMERS
5.3.1. DRIVERS
5.3.1.1. Biodegradable naturally
5.3.1.2. Compatibility in imaging1
5.3.2. INHIBITORS AND OPPORTUNITIES
5.3.3. TOP PLAYER ANALYSIS OF POLYMER BIOMATERIAL MARKET
5.3.4. NATURAL POLYMERS
5.3.4.1. Drivers
5.3.4.1.1. Safe to use
5.3.4.1.2. They work at a molecular level
5.3.4.2. Inhibitors and opportunities
5.3.4.3. Collagen-based biomaterials
5.3.4.3.1. Drivers
5.3.4.3.1.1. Role in tissue regeneration and cellular development
5.3.4.3.1.2. Antigenic properties
5.3.4.3.1.3. Biodegradibility
5.3.4.4. Chitosan
5.3.4.5. Alginate
5.3.4.6. Others natural polymers
5.3.5. SYNTHETIC POLYMERRIC BIOMATERIALS
5.3.5.1. Hyaluronic acid (HA)
5.3.5.2. PLA/PGA (poly lactic acid/Poly lactic-co glycolic acid)
5.3.5.3. PTFE (polytetrafluoroethylene)
5.3.5.4. Other synthetic polymers
6. APPLICATION MARKET
6.1. GENERAL SURGERY
6.1.1. DRIVERS
6.1.1.1. Synthetic biomaterials make suturing easier
6.1.1.2. Biomaterials meet the stringent requirements of surgeons
6.1.1.3. Biomaterials are used as adhesion prevention materials
6.1.2. INHIBITORS AND OPPORTUNITIES
6.2. SURGICAL APPLIANCES AND SUPPLIES
6.2.1. DRIVERS
6.2.1.1. Advanced materials for surgical appliances
6.2.1.2. Advances in orthopedic and prosthetic applications
6.2.1.3. Increased healthcare spending in developed countries
6.2.1.4. Tissue engineering doesn’t have any side effects
6.2.1.5. Biomaterials accelerate natural phenomena
6.2.2. MARKET INHIBITORS
6.2.2.1. Reduced availability of outside capital
6.2.2.2. Slow approval process
6.2.3. OPPORTUNITIES
6.2.3.1. Increase in export opportunities
6.2.3.2. Future development of artificial organs
6.2.3.3. Treatment of sleep disorder
6.3. DRUG DELIVERY APPLICATIONS
6.3.1. DRIVERS
6.3.1.1. Enabling properties of biomaterials
6.3.1.2. Most biomaterials are bio-absorbable
6.3.1.3. Development of quick and effective methods
6.3.2. INHIBITORS & OPPORTUNITIES
6.3.2.1. Adverse side effects from certain biomaterials inhibits growth
6.3.2.2. Nanobiomaterials for controlled drug delivery
6.4. DENTAL PRODUCTS
6.4.1. DRIVERS
6.4.1.1. Biomaterials have wide range of dental applications
6.4.1.2. Risk of dental disease is set to increase
6.4.1.3. Improvement in polymers for dental applications
6.4.2. INHIBITORS AND OPPORTUNITIES
6.5. SURGICAL AND MEDICAL INSTRUMENTS
6.5.1. DRIVERS
6.5.1.1. Innovations in surgical instruments
6.5.1.2. Availability of cheap surgical instruments
6.5.2. INHIBITORS AND OPPORTUNITIES
6.6. ELECTRO-MEDICAL EQUIPMENT APPLICATION
6.6.1. DRIVERS
6.6.1.1. Significant increase in patient-base
6.6.1.2. Demand for efficient procedures and economies of scale
6.6.2. INHIBITORS AND OPPORTUNITIES
6.7. OTHER APPLICATIONS
7. GEOGRAPHIC ANALYSIS OF BIOMATERIAL MARKET
7.1. U.S. BIOMATERIAL MARKET
7.2. EUROPE BIOMATERIAL MARKET
8. COMPANY PROFILES
8.1. 3DM, INC.
8.2. ADVANSOURCE BIOMATERIALS CORPORATION
8.3. ALLERGAN INC.
8.4. ALLOSOURCE
8.5. ALPHATEC SPINE, INC.
8.6. AMEDICA CORPORATION
8.7. ANGIOTECH PHARMACEUTICALS, INC.
8.8. APATECH LTD.
8.9. ARTIMPLANT AB
8.10. BIOCORAL, INC.
8.11. BIOINTERACTIONS LTD.
8.12. BIORETEC LTD.
8.13. BIO SYNTECH CANADA INC.
8.14. BOSTON SCIENTIFIC CORPORATION
8.15. COLLAGEN MATRIX, INC.
8.16. CORIN GROUP PLC
8.16.1. STRATEGIES
8.17. COVALON TECHNOLOGIES
8.18. CRYOLIFE INC.
8.19. DAVOL, INC.
8.20. DEPUY ORTHOPAEDICS INC.
8.20.1. STRATEGIES & DEVELOPMENTS
8.21. ETEX CORPORATION
8.22. FORTICELL BIOSCIENCE, INC.
8.23. GENZYME BIOSURGERY
8.24. HAEMACURE CORPORATION
8.24.1. STRATEGIES & DEVELOPMENTS
8.25. INION OY
8.25.1. DEVELOPMENTS
8.26. INTEGRA LIFESCIENCES HOLDINGS CORP.
8.27. INTERNATIONAL BIOCOMPOSITES LTD.
8.28. INVIBIO LTD.
8.29. ISTO TECHNOLOGIES, INC.
8.30. KENSEY NASH CORPORATION
8.31. MEDTRONIC, INC.
8.31.1. STRATEGIES & DEVELOPMENTS
8.32. MENTOR CORPORATION
8.33. MIV THERAPEUTICS INC.
8.33.1. STRATEGIES & DEVELOPMENTS
8.34. OLYMPUS TERUMO BIOMATERIALS LTD.
8.35. ORGANOGENESIS, INC.
8.35.1. DEVELOPMENTS
8.36. ORTHOVITA
8.37. OSTEOTECH, INC.
8.38. DEVELOPMENTS
8.39. PIONEER SURGICAL TECHNOLOGY
8.39.1. STRATEGIES
8.40. POLYMER TECHNOLOGY GROUP
8.41. PROTEIN POLYMER TECHNOLOGIES INC.
8.41.1. STRATEGIES & DEVELOPMENTS
8.42. RTI BIOLOGICS, INC.
8.43. SMITH & NEPHEW PLC
8.44. SYNTHES, INC.
8.45. TEI BIOSCIENCES
8.46. TORNIER INC.
8.47. VYGON S.A
8.48. W.L. GORE & ASSOCIATES INC.
8.49. WRIGHT MEDICAL GROUP, INC.
8.50. ZIMMER HOLDING, INC.
9. PATENT ANALYSIS
APPENDIX
U.S. BIOMATERIAL PRODUCT PATENTS
EUROPE BIOMATERIAL PRODUCT PATENTS
ASIA BIOMATERIAL PRODUCT PATENTS
U.S. BIOMATERIAL PATENTS
EUROPE BIOMATERIAL PATENT
ASIA BIOMATERIAL PATENTS
1.1. KEY TAKE-AWAYS
1.2. MARKET COVERED
1.3. REPORT DESCRIPTION
1.4. STAKEHOLDERS
2. SUMMARY
3. MARKET OVERVIEW
3.1. DRIVING FACTOR ANALYSIS OF GLOBAL BIOMATERIAL MARKET
3.1.1. SUPPLY SIDE DRIVERS
3.1.2 DEMAND SIDE DRIVERS
3.1.3. RESTRAINTS
3.1.4. OPPORTUNITIES
3.1.5. KEY COMPETITIVE POINTS
3.2. DEFINING THE GLOBAL BIOMATERIAL MARKET
3.3. DEFINING THE BIOMATERIAL DEVICE MARKET
3.4. DRIVERS
3.4.1. NEW AND IMPROVED TECHNOLOGIES
3.4.2. DEVELOPMENTS IN BIOCOMPATIBILITY SCIENCE
3.4.3. LARGE APPLICATION AREA
3.4.4 INTRODUCTION OF BIO-ABSORBABLE BIOMATERIALS
3.4.5. RISING AWARENESS
3.4.6 MEDICAL APPLICATIONS OF SYNTHETIC BIOMATERIALS
3.4.7. BIOMATERIALS HELP TREAT AGE-RELATED PROBLEMS
3.4.8. MEDICAL INSURANCE COVERAGE
3.4.9. RECENT DEVELOPMENTS IN BIOMATERIAL RESEARCH
3.4.10. INCREASING FOCUS ON PERSONAL HEALTHCARE
3.5. INHIBITORS
3.5.1. LACK OF TISSUE AVAILABILITY
3.5.2. LACK OF PROPER REIMBURSEMENT FACILITIES
3.6. OPPORTUNITIES
3.6.1. MARKET PARTICIPATION BY SMALLER COMPANIES
3.6.2. GROWING NEED FOR INTEGRATED AND COMBINED MATERIALS
3.6.3. INTELLIGENT MATERIALS WITH DYNAMIC MOLECULAR FUNCTIONS
3.6.4. EMERGING PREFERENCE FOR MINIMALLY INVASIVE SURGERY
4. BIOMATERIAL PRODUCT MARKET
4.1. ORTHOPEDIC BIOMATERIALS
4.1.1. DRIVERS
4.1.1.1. Product penetration
4.1.1.2. Increasing use of orthopedic biomaterials in spine surgery
4.1.1.3. Easy surgical procedures
4.1.2. INHIBITORS
4.1.2.1. Economic constraints
4.1.2.2. Increasing competition lessens profit margin
4.1.3. OPPORTUNITIES
4.1.3.1. Spinal treatment expected to be on the rise
4.1.4. TOP PLAYER ANALYSIS OF ORTHOPEDIC BIOMATERIAL MARKET
4.1.5. RTHOPEDIC RECONSTRUCTIVE BIOMATERIALS
4.1.5.1. Drivers
4.1.5.1.1. Wide range of products available for specific applications
4.1.5.1.2. Development of new materials with improved properties
4.1.5.2. Market inhibitors and opportunities
4.1.5.3. Top Players analysis in Orthopedic Reconstructive market
4.1.5.4. Artificial hip biomaterial market
4.1.5.4.1. Cemented prostheses biomaterial market
4.1.5.4.2. Uncemented prostheses biomaterial market
4.1.5.5. Artificial knee biomaterial market
4.1.5.5.1. Non-constraint implants
4.1.5.5.2. Semi-constraint implants
4.1.5.5.3. Constraint implants
4.1.6. TRAUMA BIOMATERIALS
4.1.6.1. Drivers
4.1.6.1.1. Sports injuries and other accidents
4.1.6.1.2. Plate and screw systems spur overall market growth
4.1.6.2. Top Players Analysis of Trauma Orthopedic Biomaterial Market
4.1.7. ORTHOBIOLOGIC BIOMATERIALS 56
4.1.7.1. Top player analysis of orthobiologics biomaterial market
4.1.7.2. DBM
4.1.7.3. Machined bone allografts
4.1.7.4. Non-proprietary allografts
4.1.7.5. Synthetic bone substitute
4.1.7.6. Bone morphogenic protein (BMP)
4.1.7.7. Platelet concentrates
4.1.8. SPORTS MEDICINE BIOMATERIALS
4.1.8.1. Market Drivers
4.1.8.2. Top player analysis of sports medicine orthopedic biomaterial market
4.1.9. BONE CEMENT
4.1.9.1. Market Drivers
4.1.9.1.1. Bone cements ease lesions and can be used with antibiotics
4.1.9.2. Inhibitors and opportunities
4.1.9.3. Top player analysis of bone cement orthopedic biomaterial market
4.1.10.SPINAL BIOMATERIALS
4.1.10.1.Drivers
4.1.10.1.1. Spinal treatment for younger patients on the rise
4.1.10.1.2. Motio- preserving devices drive growth
4.1.10.2.Inhibitors & Opportunities
4.1.10.2.1. Reimbursement challenges restrain growth
4.1.10.2.2. Technology and product development will provide scope for improvement
4.1.10.3.Top player analysis of spine orthopedic biomaterial market
4.1.10.4.Cervical Biomaterials
4.1.10.5.Lumbar Biomaterials
4.1.11.DENTAL BIOMATERIALS
4.1.11.1.Drivers
4.1.11.2.Inhibitors and opportunities
4.1.11.3.Top player analysis of dental orthopedic biomaterial market
4.1.11.4.Dental bone grafts and substitutes
4.1.11.5.Allograft
4.1.11.6.Xenograft
4.1.11.7.Synthetic dental bone graft and substitute market
4.1.11.8.Tissue regeneration
4.1.11.9.Dental membranes
4.2. CARDIOVASCULAR BIOMATERIALS
4.2.1. DRIVERS
4.2.1.1. Biomaterials enhance cardiovascular treatment
4.2.1.2. Rising number of obesity cases
4.2.1.3. Increase in thrombosis and heart failure treatments
4.2.1.4. Vascular surgery market is growing with the uses of biomaterials
4.2.2. INHIBITORS AND OPPORTUNITIES
4.2.3. TOP PLAYER ANALYSIS OF CARDIOVASCULAR BIOMATERIALS MARKET
4.2.4. CARDIAC PACEMAKERS BIOMATERIAL MARKET
4.2.4.1. Top player analysis of cardiac pacemaker cardiovascular biomaterial market
4.2.5. IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
4.2.5.1. Top player analysis of implantable cardioverter defibrillator cardiovascular biomaterial market
4.2.6. CARDIAC STENT
4.2.6.1. Top player analysis of cardiac stents biomaterial market
4.2.7. ARTIFICIAL HEART VALVES
4.2.7.1. Top player analysis of artificial heart valve cardiovascular biomaterial market
4.2.8. VASCULAR ACCESS DEVICES
4.2.8.1. Drivers & Inhibitors
4.2.8.2. Top player analysis of vascular access devices biomaterial market
4.2.9. PERIPHERAL VASCULAR GRAFTS
4.3. WOUND CARE BIOMATERIALS
4.3.1. DRIVERS
4.3.1.1. Multiple advantages over conventional wound care products
4.3.1.2. Supports healing process of the skin
4.3.1.3. Gel-based products accelerate wound healing
4.3.1.4. Prevention of bacterial colonization on sutures
4.3.1.5. Reduction in the cost of hospitalization
4.3.1.6. Eliminates frequent change of dressings
4.3.1.7. Increase in diabetes foot ulcer
4.3.2. INHIBITORS
4.3.2.1. Slow rate of product development
4.3.3. OPPORTUNITIES
4.3.3.1. Increase in penetration of negative pressure wound
4.3.3.2. Introduction of more efficient and cost effective therapies
4.3.3.3. Use of natural polymer biomaterials for stability in treatment
4.3.4. TOP PLAYER ANALYSIS OF WOUND CARE BIOMATERIAL MARKET
4.3.5. INTERNAL TISSUE SEALANT
4.3.5.1. Drivers
4.3.5.1.1. Technological advances
4.3.5.1.2. Wide range of applications and features
4.3.5.1.3. Faster healing
4.3.5.2. Top player analysis of internal tissue sealant wound care biomaterial market
4.3.5.3. Fibrin Sealants
4.3.5.4. Synthetic sealants
4.3.6. SURGICAL HEMOSTATS
4.3.6.1. Drivers
4.3.6.1.1. Surgical hemostats control bleeding
4.3.6.1.2. Reduces the need for frequent blood transfusions
4.3.6.2. Top player analysis of surgical hemostats market
4.3.6.3. Thrombin-based hemostats
4.3.6.4. Oxidized regenerated cellulose based topical hemostats
4.3.6.5. Gelatin-based hemostats
4.3.6.6. Combination hemostats
4.3.6.7. Collagen-based hemostats
4.3.6.8. Autologous-based hemostats
4.3.6.9. Polysaccharide-based hemostats
4.3.7. ADHESION BARRIERS
4.3.7.1. Drivers
4.3.7.2. Inhibitors and opportunities
4.3.7.3. Top player analysis of adhesion prevention wound care biomaterial market
4.3.7.4. Films
4.3.7.5. Gels
4.3.8. SKIN SUBSTITUTES
4.4. GASTROINTESTINAL BIOMATERIALS
4.4.1. DRIVERS
4.4.1.1. Increasing incidence of gastrointestinal diseases
4.4.1.2. FDA approval for OTC gastrointestinal drugs
4.4.2. INHIBITORS AND OPPORTUNITIES
4.4.3. TOP PLAYER ANALYSIS OF GASTROINTESTINAL BIOMATERIAL MARKET
4.5. UROLOGICAL BIOMATERIALS
4.5.1. DRIVERS
4.5.1.1. Availability of biodegradable materials for treatment
4.5.1.2. Development of scaffolds for the treatment of several disorders
4.5.2. INHIBITORS AND OPPORTUNITIES
4.5.3. TOP PLAYER ANALYSIS OF UROLOGICAL BIOMATERIAL MARKET
4.5.4. UROLOGICAL STENTS
4.5.4.1. Market Drivers
4.5.4.1.1. Stents are used in short duration treatment
4.5.4.1.2. Broad indications and growing population
4.5.4.2. Inhibitors and Opportunities
4.5.5. UROLOGICAL CATHETERS
4.5.5.1. Drivers & Inhibitors
4.5.5.1.1. Developments in catheter design have increased applicability
4.5.5.1.2. Prolonged use of catheters may lead to cancer
4.5.5.2. Opportunities
4.5.5.2.1. Use of biomaterials in catheters eliminates certain disadvantages
4.5.5.2.2. Biocompatibility of chemicals can be improved in catheters
4.5.5.3. Dialysis catheter
4.5.5.3.1. Top player analysis of dialysis catheter market
4.5.5.3.2. Hemodialysis catheter
4.5.5.3.3. Peritonial catheter
4.5.5.4. Urinary catheter
4.5.5.4.1. Indwelling catheter
4.5.5.4.2. External catheter
4.5.5.4.3. Intermittent catheter
4.6. PLASTIC SURGERY BIOMATERIALS
4.6.1. DRIVERS
4.6.1.1. Baby boomers to boost market growth
4.6.1.2. More surgeons are moving towards plastic surgery market from reconstructive procedures
4.6.1.3. Cultural factors boost the market growth
4.6.2. INHIBITORS & OPPORTUNITIES
4.6.2.1. Difficulties in treating craniofacial trauma
4.6.2.2. Male population untapped for facial surgeries
4.6.3. TOP PLAYER ANALYSIS OF PLASTIC SURGERY BIOMATERIAL MARKET
4.6.4. REAST IMPLANTS
4.6.4.1. Drivers
4.6.4.1.1. Availability of more refined procedures and wide range of choice
4.6.4.2. Inhibitors & opportunities
4.6.4.3. Top player analysis of breast implants biomaterial market
4.6.4.4. Saline-filled implants
4.6.4.5. Silicone-filled implants
4.6.5. INJECTABLE FILLERS
4.6.5.1. Drivers
4.6.5.1.1. Increase in awareness of skin care
4.6.5.1.2. Permanent results can be achieved using fillers
4.6.5.2. Inhibitors & opportunities
4.6.5.2.1. Allergy
4.6.5.3. Top player analysis of injectable fillers biomaterial market
4.6.6. FACIAL IMPLANTS
4.6.6.1. Drivers
4.6.6.1.1. Iraq war increased the demand for facial implants
4.6.6.1.2. Faster recovery and surgery times
4.6.6.2. Inhibitors and opportunities
4.6.6.3. Top player analysis of facial implants biomaterial market
4.7. OTHER BIOMATERIALS
5. BIOMATERIAL MARKET
5.1. CERAMICS
5.1.1. TOP PLAYER ANALYSIS OF CERAMICS BIOMATERIAL MARKET
5.1.2. BIOINERT CERAMICS
5.1.2.1. Drivers
5.1.2.1.1. Compatibility with high-strength applications
5.1.2.1.2. High chemical stability
5.1.2.2. Inhibitors and opportunities
5.1.2.3. Alumina
5.1.2.4. Zirconia ceramic
5.1.2.5. Other bioinert ceramics market
5.1.3. BIOACTIVE CERAMICS
5.1.3.1. Drivers
5.1.3.1.1. Ceramics aid bone formation
5.1.3.2. Inhibitors and Opportunities
5.1.3.3. Bioglass
5.1.3.4. Other bioactive ceramics market
5.1.4. BIODEGRADABLE CERAMICS
5.1.4.1. Hydroxyapetite
5.1.4.2. Others biodegradable biomaterial market
5.2. BIOMATERIAL METALS
5.2.1. DRIVERS
5.2.1.1. Balancing act of metallic biomaterials
5.2.1.2. Improved properties of metallic biomaterials
5.2.2. INHIBITORS
5.2.2.1. Corrosion may occur in the implant
5.2.3. OPPORTUNITIES
5.2.3.1. Improvement in corrosion resistance
5.2.3.2. Introduction of new alloys
5.2.4. TOP PLAYER ANALYSIS OF METALLIC BIOMATERIAL MARKET
5.2.5. PURE FORM METALS
5.2.5.1. Titanium
5.2.5.2. Gold
5.2.5.3. Silver
5.2.5.4. Platinum
5.2.6. ALLOYS
5.2.6.1. Drivers
5.2.6.1.1. Can be sterilized easily
5.2.6.2. Inhibitors and opportunities
5.2.6.3. Top player analysis of alloy biomaterial market
5.2.6.4. High Carbon Cobalt Chromium Alloy
5.3. POLYMERS
5.3.1. DRIVERS
5.3.1.1. Biodegradable naturally
5.3.1.2. Compatibility in imaging1
5.3.2. INHIBITORS AND OPPORTUNITIES
5.3.3. TOP PLAYER ANALYSIS OF POLYMER BIOMATERIAL MARKET
5.3.4. NATURAL POLYMERS
5.3.4.1. Drivers
5.3.4.1.1. Safe to use
5.3.4.1.2. They work at a molecular level
5.3.4.2. Inhibitors and opportunities
5.3.4.3. Collagen-based biomaterials
5.3.4.3.1. Drivers
5.3.4.3.1.1. Role in tissue regeneration and cellular development
5.3.4.3.1.2. Antigenic properties
5.3.4.3.1.3. Biodegradibility
5.3.4.4. Chitosan
5.3.4.5. Alginate
5.3.4.6. Others natural polymers
5.3.5. SYNTHETIC POLYMERRIC BIOMATERIALS
5.3.5.1. Hyaluronic acid (HA)
5.3.5.2. PLA/PGA (poly lactic acid/Poly lactic-co glycolic acid)
5.3.5.3. PTFE (polytetrafluoroethylene)
5.3.5.4. Other synthetic polymers
6. APPLICATION MARKET
6.1. GENERAL SURGERY
6.1.1. DRIVERS
6.1.1.1. Synthetic biomaterials make suturing easier
6.1.1.2. Biomaterials meet the stringent requirements of surgeons
6.1.1.3. Biomaterials are used as adhesion prevention materials
6.1.2. INHIBITORS AND OPPORTUNITIES
6.2. SURGICAL APPLIANCES AND SUPPLIES
6.2.1. DRIVERS
6.2.1.1. Advanced materials for surgical appliances
6.2.1.2. Advances in orthopedic and prosthetic applications
6.2.1.3. Increased healthcare spending in developed countries
6.2.1.4. Tissue engineering doesn’t have any side effects
6.2.1.5. Biomaterials accelerate natural phenomena
6.2.2. MARKET INHIBITORS
6.2.2.1. Reduced availability of outside capital
6.2.2.2. Slow approval process
6.2.3. OPPORTUNITIES
6.2.3.1. Increase in export opportunities
6.2.3.2. Future development of artificial organs
6.2.3.3. Treatment of sleep disorder
6.3. DRUG DELIVERY APPLICATIONS
6.3.1. DRIVERS
6.3.1.1. Enabling properties of biomaterials
6.3.1.2. Most biomaterials are bio-absorbable
6.3.1.3. Development of quick and effective methods
6.3.2. INHIBITORS & OPPORTUNITIES
6.3.2.1. Adverse side effects from certain biomaterials inhibits growth
6.3.2.2. Nanobiomaterials for controlled drug delivery
6.4. DENTAL PRODUCTS
6.4.1. DRIVERS
6.4.1.1. Biomaterials have wide range of dental applications
6.4.1.2. Risk of dental disease is set to increase
6.4.1.3. Improvement in polymers for dental applications
6.4.2. INHIBITORS AND OPPORTUNITIES
6.5. SURGICAL AND MEDICAL INSTRUMENTS
6.5.1. DRIVERS
6.5.1.1. Innovations in surgical instruments
6.5.1.2. Availability of cheap surgical instruments
6.5.2. INHIBITORS AND OPPORTUNITIES
6.6. ELECTRO-MEDICAL EQUIPMENT APPLICATION
6.6.1. DRIVERS
6.6.1.1. Significant increase in patient-base
6.6.1.2. Demand for efficient procedures and economies of scale
6.6.2. INHIBITORS AND OPPORTUNITIES
6.7. OTHER APPLICATIONS
7. GEOGRAPHIC ANALYSIS OF BIOMATERIAL MARKET
7.1. U.S. BIOMATERIAL MARKET
7.2. EUROPE BIOMATERIAL MARKET
8. COMPANY PROFILES
8.1. 3DM, INC.
8.2. ADVANSOURCE BIOMATERIALS CORPORATION
8.3. ALLERGAN INC.
8.4. ALLOSOURCE
8.5. ALPHATEC SPINE, INC.
8.6. AMEDICA CORPORATION
8.7. ANGIOTECH PHARMACEUTICALS, INC.
8.8. APATECH LTD.
8.9. ARTIMPLANT AB
8.10. BIOCORAL, INC.
8.11. BIOINTERACTIONS LTD.
8.12. BIORETEC LTD.
8.13. BIO SYNTECH CANADA INC.
8.14. BOSTON SCIENTIFIC CORPORATION
8.15. COLLAGEN MATRIX, INC.
8.16. CORIN GROUP PLC
8.16.1. STRATEGIES
8.17. COVALON TECHNOLOGIES
8.18. CRYOLIFE INC.
8.19. DAVOL, INC.
8.20. DEPUY ORTHOPAEDICS INC.
8.20.1. STRATEGIES & DEVELOPMENTS
8.21. ETEX CORPORATION
8.22. FORTICELL BIOSCIENCE, INC.
8.23. GENZYME BIOSURGERY
8.24. HAEMACURE CORPORATION
8.24.1. STRATEGIES & DEVELOPMENTS
8.25. INION OY
8.25.1. DEVELOPMENTS
8.26. INTEGRA LIFESCIENCES HOLDINGS CORP.
8.27. INTERNATIONAL BIOCOMPOSITES LTD.
8.28. INVIBIO LTD.
8.29. ISTO TECHNOLOGIES, INC.
8.30. KENSEY NASH CORPORATION
8.31. MEDTRONIC, INC.
8.31.1. STRATEGIES & DEVELOPMENTS
8.32. MENTOR CORPORATION
8.33. MIV THERAPEUTICS INC.
8.33.1. STRATEGIES & DEVELOPMENTS
8.34. OLYMPUS TERUMO BIOMATERIALS LTD.
8.35. ORGANOGENESIS, INC.
8.35.1. DEVELOPMENTS
8.36. ORTHOVITA
8.37. OSTEOTECH, INC.
8.38. DEVELOPMENTS
8.39. PIONEER SURGICAL TECHNOLOGY
8.39.1. STRATEGIES
8.40. POLYMER TECHNOLOGY GROUP
8.41. PROTEIN POLYMER TECHNOLOGIES INC.
8.41.1. STRATEGIES & DEVELOPMENTS
8.42. RTI BIOLOGICS, INC.
8.43. SMITH & NEPHEW PLC
8.44. SYNTHES, INC.
8.45. TEI BIOSCIENCES
8.46. TORNIER INC.
8.47. VYGON S.A
8.48. W.L. GORE & ASSOCIATES INC.
8.49. WRIGHT MEDICAL GROUP, INC.
8.50. ZIMMER HOLDING, INC.
9. PATENT ANALYSIS
APPENDIX
U.S. BIOMATERIAL PRODUCT PATENTS
EUROPE BIOMATERIAL PRODUCT PATENTS
ASIA BIOMATERIAL PRODUCT PATENTS
U.S. BIOMATERIAL PATENTS
EUROPE BIOMATERIAL PATENT
ASIA BIOMATERIAL PATENTS
LIST OF TABLES
SUMMARY TABLE GLOBAL BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014($ MILLION)
TABLE 1 GLOBAL ORTHOPEDIC BIOMATERIAL DEVICE MARKET, BY TYPES2007 – 2014 ($ MILLION)
TABLE 2 GLOBAL ORTHOPEDIC BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014($ MILLION)
TABLE 3 GLOBAL ORTHOPEDIC BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 4 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 5 GLOBAL RECONSTRUCTIVE ORTHOPEDIC BIOMATERIAL DEVICE MARKET BY TYPES 2007 – 2014 ($ MILLION)
TABLE 6 GLOBAL RECONSTRUCTIVE ORTHOPEDIC BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 7 GLOBAL RECONSTRUCTIVE ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 8 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 9 GLOBAL ARTIFICIAL HIP ORTHOPEDIC BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 10 GLOBAL ARTIFICIAL HIP ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 11 GLOBAL CEMENTED PROSTHESES ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 12 GLOBAL UNCEMENTED PROSTHESES ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 13 GLOBAL ARTIFICIAL KNEE ORTHOPEDIC BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 14 GLOBAL ARTIFICIAL KNEE ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 15 GLOBAL NON-CONSTRAINT IMPLANTS ORTHOPEDIC BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLIONS)
TABLE 16 GLOBAL SEMI-CONSTRAINT ORTHOPEDIC BIOMATERIALS MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 17 GLOBAL CONSTRAINT IMPLANTS ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 18 GLOBAL TRAUMA ORTHOPEDIC BIOMATERIAL DEVICE MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 19 GLOBAL TRAUMA ORTHOPEDIC BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 20 GLOBAL TRAUMA ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 21 MAJOR PLAYERS AND THEIR RESPECTIVE PRODUCT DEVELOPMENTS
TABLE 22 GLOBAL ORTHOBIOLOGICS BIOMATERIAL MARKET, BY DEVICE 2007 – 2014 ($ MILLION)
TABLE 23 GLOBAL ORTHOBIOLOGICS BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 24 GLOBAL ORTHOBIOLOGICS BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 25 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 26 GLOBAL DBM ORTHOPEDIC BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 27 GLOBAL MACHINED BONE ALLOGRAFT ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 28 GLOBAL NON-PROPRIETARY ALLOGRAFT ORTHOPEDIC MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 29 GLOBAL SYNTHETIC BONE SUBSTITUTE ORTHOPEDIC BIOMATERIALS MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 30 GLOBAL BMP ORTHOPEDIC BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 31 GLOBAL PLATELET CONCENTRATES ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 32 GLOBAL SPORTS MEDICINE ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 33 MAJOR PLAYERS AND PRODUCT DEVELOPMENTZ
TABLE 34 GLOBAL BONE CEMENT ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 35 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 36 GLOBAL SPINE ORTHOPEDIC BIOMATERIAL MARKET, BY DEVICE 2007 – 2014 ($ MILLION)
TABLE 37 GLOBAL SPINE ORTHOPEDIC BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 38 GLOBAL SPINE ORTHOPEDIC BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 39 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 40 GLOBAL CERVICAL SPINE ORTHOPEDIC BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 41 GLOBAL CERVICAL SPINE ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 42 GLOBAL LUMBAR SPINE ORTHOPEDIC BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 43 GLOBAL LUMBAR SPINE ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 44 GLOBAL DENTAL ORTHOPEDIC BIOMATERIAL DEVICE MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 45 GLOBAL DENTAL ORTHOPEDIC BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 46 GLOBAL DENTAL ORTHOPEDIC BIOMATERIALS MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 47 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 48 GLOBAL DENTAL BONE GRAFT ORTHOPEDIC BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 49 GLOBAL DENTAL BONE GRAFT ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY, 2007 – 2014 ($ MILLION)
TABLE 50 GLOBAL DENTAL ALLOGRAFT ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 51 GLOBAL XENOGRAFT DENTAL BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 52 GLOBAL SYNTHETIC DENTAL BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 53 GLOBAL TISSUE REGENERATION DENTAL BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 54 GLOBAL DENTAL MEMBRANE BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 55 GLOBAL CARDIOVASCULAR BIOMATERIAL MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 56 GLOBAL CARDIOVASCULAR BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 57 GLOBAL CARDIOVASCULAR BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 58 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 59 GLOBAL CARDIAC PACEMAKER CARDIOVASCULAR DEVICE MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 60 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 61 GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR CARDIOVASCULAR BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 62 MAJOR PLAYERS AND THEIR RESPECTIVE PRODUCT DEVELOPMENTS
TABLE 63 GLOBAL CARDIAC STENTS CARDIOVASCULAR BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 64 GLOBAL CARDIAC STENTS CARDIOVASCULAR BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 65 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 66 GLOBAL ARTIFICIAL HEART VALVE CARDIOVASCULAR BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 67 GLOBAL ARTIFICIAL HEART VALVE CARDIOVASCULAR BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 68 MAJOR PLAYERS AND THEIR RESPECTIVE DEVELOPMENTS
TABLE 69 GLOBAL VASCULAR ACCESS DEVICES CARDIOVASCULAR BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 70 GLOBAL VASCULAR ACCESS DEVICES CARDIOVASCULAR BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 71 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 72 GLOBAL PERIPHERAL VASCULAR GRAFTS MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 73 GLOBAL WOUND CARE BIOMATERIAL DEVICE MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 74 GLOBAL WOUND CARE BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 75 GLOBAL WOUND CARE BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 76 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 77 GLOBAL INTERNAL TISSUE SEALANT WOUND CARE BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 78 GLOBAL INTERNAL TISSUE SEALANT WOUND CARE BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 79 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 80 GLOBAL FIBRIN-BASED SEALANT WOUND CARE BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 81 GLOBAL SYNTHETIC BASED SEALANT WOUND CARE BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 82 GLOBAL SURGICAL HEMOSTATS WOUND CARE BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 83 GLOBAL SURGICAL HEMOSTATS WOUND CARE BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 84 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 85 GLOBAL THROMBIN BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 86 GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 87 GLOBAL GELATIN BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 88 GLOBAL COMBINATION HEMOSTATS WOUND CARE BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 89 GLOBAL COLLAGEN BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 90 GLOBAL AUTOLOGOUS BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 91 GLOBAL POLYSACCHARIDE BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 92 GLOBAL ADHESION BARRIERS WOUND CARE MARKET, BY PRODUCTS2007 – 2014 ($ MILLION)
TABLE 93 GLOBAL ADHESION BARRIERS WOUND CARE MARKET, BY GEOGRAPHY2007 – 2014 ($ MILLION)
TABLE 94 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 95 GLOBAL FILMS WOUND CARE BIOMATERIAL MARKET, BY GEOGRAPHY2007 – 2014 ($ MILLION)
TABLE 96 GLOBAL GELS WOUND CARE BIOMATERIAL MARKET, BY GEOGRAPHY2007 – 2014 ($ MILLION)
TABLE 97 GLOBAL SKIN SUBSTITUTE WOUND CARE BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 98 GLOBAL GASTROINTESTINAL BIOMATERIAL MARKET, BY GEOGRAPHY2007 – 2014 ($ MILLION)
TABLE 99 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 100 GLOBAL UROLOGICAL BIOMATERIAL DEVICE MARKET, BY TYPES2007 – 2014 ($ MILLION)
TABLE 101 GLOBAL UROLOGICAL BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014($ MILLION)
TABLE 102 GLOBAL UROLOGICAL BIOMATERIAL MARKET, BY GEOGRAPHY2007 – 2014 ($ MILLION)
TABLE 103 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS 116
TABLE 104 GLOBAL STENTS UROLOGICAL BIOMATERIAL MARKET, BY GEOGRAPHY2007 – 2014 ($ MILLION)
TABLE 105 GLOBAL CATHETER UROLOGICAL BIOMATERIAL MARKET, BY PRODUCTS2007 – 2014 ($ MILLION)
TABLE 106 GLOBAL CATHETERS UROLOGICAL BIOMATERIAL MARKET, BY GEOGRAPHY2007 – 2014 ($ MILLION)
TABLE 107 GLOBAL DIALYSIS CATHETER UROLOGICAL BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 108 GLOBAL DIALYSIS CATHETER UROLOGICAL BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 109 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 110 GLOBAL HEMODIALYSIS CATHETER UROLOGICAL BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 111 GLOBAL PERITONIAL CATHETER UROLOGICAL BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 112 GLOBAL URINARY CATHETER UROLOGICAL BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 113 GLOBAL URINARY CATHETERS UROLOGICAL BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 114 GLOBAL INDWELLING CATHETER UROLOGICAL BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 115 GLOBAL PLASTIC SURGERY BIOMATERIAL DEVICE MARKET, BY TYPES2007 – 2014 ($ MILLION)
TABLE 116 GLOBAL PLASTIC SURGERY BIOMATERIAL MARKET, BY PRODUCTS2007 – 2014 ($ MILLION)
TABLE 117 GLOBAL PLASTIC SURGERY BIOMATERIAL MARKET, BY GEOGRAPHY2007 – 2014 ($ MILLION)
TABLE 118 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 119 GLOBAL BREAST IMPLANTS PLASTIC SURGERY BIOMATERIAL DEVICE MARKET BY TYPES 2007 – 2014 ($ MILLION)
TABLE 120 GLOBAL BREAST IMPLANTS PLASTIC SURGERY BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 121 GLOBAL BREAST IMPLANTS PLASTIC SURGERY BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 122 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 123 GLOBAL SALINE-FILLED BREAST IMPLANT BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 124 GLOBAL SILICONE-GEL BREAST IMPLANT BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 125 GLOBAL INJECTABLE FILLERS BREAST IMPLANT BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 126 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 127 GLOBAL FACIAL IMPLANTS PLASTIC SURGERY BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 128 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 129 GLOBAL BIOMATERIAL MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 130 GLOBAL BIOMATERIAL CERAMICS MARKET, BY TYPES 2007 – 2014($ MILLION)
TABLE 131 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 132 TECHNOLOGICAL ADVANCEMENTS IN CERAMICS MARKET
TABLE 133 GLOBAL BIOINERT CERAMICS MARKET, BY TYPES OF BIOMATERIALS2007 – 2014 ($ MILLION)
TABLE 134 GLOBAL BIOACTIVE CERAMICS MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 135 GLOBAL BIODEGRADABLE CERAMICS MARKET, BY TYPES 2007 – 2014($ MILLION)
TABLE 136 GLOBAL METALLIC BIOMATERIAL MARKET, BY TYPES 2007 – 2014($ MILLION)
TABLE 137 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 138 GLOBAL PURE FORM METALS MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 139 GLOBAL ALLOY BIOMATERIAL MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 140 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 141 GLOBAL POLYMER BIOMATERIALS MARKET, BY TYPES 2007 – 2014($ MILLION)
TABLE 142 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 143 GLOBAL NATURAL POLYMER BIOMATERIAL MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 144 GLOBAL SYNTHETIC POLYMER BIOMATERIAL MARKET, BY TYPES OF BIOMATERIALS 2007 – 2014 ($ MILLION)
TABLE 145 APPLICATION MARKET FOR BIOMATERIALS
TABLE 146 GLOBAL BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 147 U.S. BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 148 EUROPEAN BIOMATERIAL MARKET, BY PRODUCTS,2007 – 2014 ($ MILLION)
TABLE 149 ASIAN BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 150 3DM, INC. PRODUCT PROFILE
TABLE 151 3DM, INC. STRATEGY
TABLE 152 ADVANSOURCE BIOMATERIALS CORPORATION PRODUCT PROFILE
TABLE 153 ALLERGAN INC. PRODUCT PROFILE
TABLE 154 ALLOSOURCE PRODUCT PROFILE
TABLE 155 ALLOSOURCE STRATEGY
TABLE 156 ALPHATEC SPINE, INC. PRODUCT PROFILE
TABLE 157 ALPHATEC SPINE, INC. STRATEGIES AND DEVELOPMENTS
TABLE 158 AMEDICA CORPORATION PRODUCT PROFILE
TABLE 159 AMEDICA CORPORATION DEVELOPMENTS
TABLE 160 ANGIOTECH PHARMACEUTICALS, INC. PRODUCT PROFILE
TABLE 161 NGIOTECH PHARMACEUTICALS, INC. STRATEGY
TABLE 162 APATECH LTD. PRODUCT PROFILE
TABLE 163 ARTIMPLANT AB PRODUCT PROFILE
TABLE 164 ARTIMPLANT AB STRATEGIES AND DEVELOPMENTS
TABLE 165 BIOINTERACTIONS LTD. PRODUCT PROFILE
TABLE 166 BIORETEC LTD. PRODUCT PROFILE
TABLE 167 BIO SYNTECH CANADA INC. PRODUCT PROFILE
TABLE 168 BIO SYNTECH CANADA INC. STRATEGY
TABLE 169 BOSTON SCIENTIFIC CORPORATION PRODUCT PROFILE
TABLE 170 COLLAGEN MATRIX, INC. PRODUCT PROFILE
TABLE 171 COLLAGEN MATRIX, INC. STRATEGY
TABLE 172 CORIN GROUP, PLC. PRODUCT PROFILE
TABLE 173 COVALON TECHNOLOGIES PRODUCT PROFILE
TABLE 174 COVALON STRATEGY
TABLE 175 CRYOLIFE INC, PRODUCT PROFILE
TABLE 176 CRYOLIFE INC., STRATEGY
TABLE 177 DAVOL, INC. PRODUCT PROFILE
TABLE 178 DAVOL, INC. STRATEGY
TABLE 179 DEPUY ORTHOPEDICS, INC. PRODUCT PROFILE
TABLE 180 DEPUY ORTHOPEDICS, INC. STRATEGY
TABLE 181 ETEX CORPORATION PRODUCT PROFILE
TABLE 182 ETEX CORPORATION STRATEGIES AND DEVELOPMENTS
TABLE 183 GENZYME BIOSURGERY PRODUCT PROFILE
TABLE 184 GENZYME BIOSURGERY DEVELOPMENTS
TABLE 185 INION OY PRODUCT PROFILE
TABLE 186 INTEGRA LIFE SCIENCES HOLDINGS CORP. PRODUCT PROFILE
TABLE 187 INTEGRA LIFE SCIENCES HOLDINGS CORP. STRATEGY
TABLE 188 INTERNATIONAL BIOCOMPOSITES LTD. PRODUCT PROFILE
TABLE 189 INTERNATIONAL BIOCOMPOSITES LTD. DEVELOPMENTS
TABLE 190 INVIBIO LTD. PRODUCT PROFILE
TABLE 191 INVIBIO LTD. STRATEGY
TABLE 192 ISTO TECHNOLOGIES, INC. APPLICATIONS
TABLE 192 KENSEY NASH CORPORATION PRODUCT PROFILE
TABLE 193 MEDTRONIC INC. PRODUCT PROFILE
TABLE 194 MEDTRONIC INC. STRATEGIES & DEVELOPMENTS
TABLE 195 MENTOR CORPORATION PRODUCT PROFILE
TABLE 196 MIV THERAPEUTICS INC. PRODUCT PROFILE
TABLE 197 OLYMPUS TERUMO PRODUCT PROFILE
TABLE 198 OLYMPUS TERUMO STRATEGY
TABLE 199 ORGANOGENESIS, INC. PRODUCT PROFILE
TABLE 200 ORTHOVITA PRODUCT PROFILE
TABLE 201 OSTEOTECH, INC. PRODUCT PROFILE
TABLE 202 PIONEER SURGICAL TECHNOLOGY PRODUCT PROFILE
TABLE 202 PIONEER SURGICAL TECHNOLOGY STRATEGY
TABLE 203 POLYMER TECHNOLOGY GROUP PROFILE
TABLE 204 PROTEIN POLYMER TECHNOLOGIES, INC. PRODUCT PROFILE
TABLE 205 RTI BIOLOGICS PRODUCT PROFILE
TABLE 206 RTI BIOLOGICS STRATEGIES
TABLE 207 SMITH & NEPHEW PLC PRODUCT PROFILE
TABLE 208 SMITH & NEPHEW PLC STRATEGY
TABLE 209 STRYKER CORPORATION PRODUCT PROFILE
TABLE 210 SYNTHES INC. PRODUCT PROFILE
TABLE 211 SYNTHES INC. STRATEGY
TABLE 212 TEI BIOSCIENCES PRODUCT PROFILE
TABLE 213 TORNIER INC. PRODUCT PROFILE
TABLE 214 TORNIER INC. STRATEGY
TABLE 215 VYGON S.A PRODUCT PROFILE
TABLE 216 VYGON S.A STRATEGY
TABLE 217 W.L. GORE & ASSOCIATES INC. PRODUCT PROFILE
TABLE 218 WRIGHT MEDICAL GROUP, INC. PRODUCT PROFILE
TABLE 219 WRIGHT MEDICAL GROUP, INC. DEVELOPMENTS
TABLE 220 ZIMMER HOLDINGS, INC. PRODUCT PROFILE
TABLE 221 ZIMMER HOLDINGS, INC. STRATEGY
SUMMARY TABLE GLOBAL BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014($ MILLION)
TABLE 1 GLOBAL ORTHOPEDIC BIOMATERIAL DEVICE MARKET, BY TYPES2007 – 2014 ($ MILLION)
TABLE 2 GLOBAL ORTHOPEDIC BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014($ MILLION)
TABLE 3 GLOBAL ORTHOPEDIC BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 4 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 5 GLOBAL RECONSTRUCTIVE ORTHOPEDIC BIOMATERIAL DEVICE MARKET BY TYPES 2007 – 2014 ($ MILLION)
TABLE 6 GLOBAL RECONSTRUCTIVE ORTHOPEDIC BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 7 GLOBAL RECONSTRUCTIVE ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 8 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 9 GLOBAL ARTIFICIAL HIP ORTHOPEDIC BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 10 GLOBAL ARTIFICIAL HIP ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 11 GLOBAL CEMENTED PROSTHESES ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 12 GLOBAL UNCEMENTED PROSTHESES ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 13 GLOBAL ARTIFICIAL KNEE ORTHOPEDIC BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 14 GLOBAL ARTIFICIAL KNEE ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 15 GLOBAL NON-CONSTRAINT IMPLANTS ORTHOPEDIC BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLIONS)
TABLE 16 GLOBAL SEMI-CONSTRAINT ORTHOPEDIC BIOMATERIALS MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 17 GLOBAL CONSTRAINT IMPLANTS ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 18 GLOBAL TRAUMA ORTHOPEDIC BIOMATERIAL DEVICE MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 19 GLOBAL TRAUMA ORTHOPEDIC BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 20 GLOBAL TRAUMA ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 21 MAJOR PLAYERS AND THEIR RESPECTIVE PRODUCT DEVELOPMENTS
TABLE 22 GLOBAL ORTHOBIOLOGICS BIOMATERIAL MARKET, BY DEVICE 2007 – 2014 ($ MILLION)
TABLE 23 GLOBAL ORTHOBIOLOGICS BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 24 GLOBAL ORTHOBIOLOGICS BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 25 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 26 GLOBAL DBM ORTHOPEDIC BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 27 GLOBAL MACHINED BONE ALLOGRAFT ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 28 GLOBAL NON-PROPRIETARY ALLOGRAFT ORTHOPEDIC MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 29 GLOBAL SYNTHETIC BONE SUBSTITUTE ORTHOPEDIC BIOMATERIALS MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 30 GLOBAL BMP ORTHOPEDIC BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 31 GLOBAL PLATELET CONCENTRATES ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 32 GLOBAL SPORTS MEDICINE ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 33 MAJOR PLAYERS AND PRODUCT DEVELOPMENTZ
TABLE 34 GLOBAL BONE CEMENT ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 35 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 36 GLOBAL SPINE ORTHOPEDIC BIOMATERIAL MARKET, BY DEVICE 2007 – 2014 ($ MILLION)
TABLE 37 GLOBAL SPINE ORTHOPEDIC BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 38 GLOBAL SPINE ORTHOPEDIC BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 39 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 40 GLOBAL CERVICAL SPINE ORTHOPEDIC BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 41 GLOBAL CERVICAL SPINE ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 42 GLOBAL LUMBAR SPINE ORTHOPEDIC BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 43 GLOBAL LUMBAR SPINE ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 44 GLOBAL DENTAL ORTHOPEDIC BIOMATERIAL DEVICE MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 45 GLOBAL DENTAL ORTHOPEDIC BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 46 GLOBAL DENTAL ORTHOPEDIC BIOMATERIALS MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 47 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 48 GLOBAL DENTAL BONE GRAFT ORTHOPEDIC BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 49 GLOBAL DENTAL BONE GRAFT ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY, 2007 – 2014 ($ MILLION)
TABLE 50 GLOBAL DENTAL ALLOGRAFT ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 51 GLOBAL XENOGRAFT DENTAL BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 52 GLOBAL SYNTHETIC DENTAL BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 53 GLOBAL TISSUE REGENERATION DENTAL BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 54 GLOBAL DENTAL MEMBRANE BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 55 GLOBAL CARDIOVASCULAR BIOMATERIAL MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 56 GLOBAL CARDIOVASCULAR BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 57 GLOBAL CARDIOVASCULAR BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 58 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 59 GLOBAL CARDIAC PACEMAKER CARDIOVASCULAR DEVICE MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 60 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 61 GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR CARDIOVASCULAR BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 62 MAJOR PLAYERS AND THEIR RESPECTIVE PRODUCT DEVELOPMENTS
TABLE 63 GLOBAL CARDIAC STENTS CARDIOVASCULAR BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 64 GLOBAL CARDIAC STENTS CARDIOVASCULAR BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 65 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 66 GLOBAL ARTIFICIAL HEART VALVE CARDIOVASCULAR BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 67 GLOBAL ARTIFICIAL HEART VALVE CARDIOVASCULAR BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 68 MAJOR PLAYERS AND THEIR RESPECTIVE DEVELOPMENTS
TABLE 69 GLOBAL VASCULAR ACCESS DEVICES CARDIOVASCULAR BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 70 GLOBAL VASCULAR ACCESS DEVICES CARDIOVASCULAR BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 71 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 72 GLOBAL PERIPHERAL VASCULAR GRAFTS MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 73 GLOBAL WOUND CARE BIOMATERIAL DEVICE MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 74 GLOBAL WOUND CARE BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 75 GLOBAL WOUND CARE BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 76 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 77 GLOBAL INTERNAL TISSUE SEALANT WOUND CARE BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 78 GLOBAL INTERNAL TISSUE SEALANT WOUND CARE BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 79 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 80 GLOBAL FIBRIN-BASED SEALANT WOUND CARE BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 81 GLOBAL SYNTHETIC BASED SEALANT WOUND CARE BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 82 GLOBAL SURGICAL HEMOSTATS WOUND CARE BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 83 GLOBAL SURGICAL HEMOSTATS WOUND CARE BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 84 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 85 GLOBAL THROMBIN BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 86 GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 87 GLOBAL GELATIN BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 88 GLOBAL COMBINATION HEMOSTATS WOUND CARE BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 89 GLOBAL COLLAGEN BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 90 GLOBAL AUTOLOGOUS BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 91 GLOBAL POLYSACCHARIDE BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 92 GLOBAL ADHESION BARRIERS WOUND CARE MARKET, BY PRODUCTS2007 – 2014 ($ MILLION)
TABLE 93 GLOBAL ADHESION BARRIERS WOUND CARE MARKET, BY GEOGRAPHY2007 – 2014 ($ MILLION)
TABLE 94 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 95 GLOBAL FILMS WOUND CARE BIOMATERIAL MARKET, BY GEOGRAPHY2007 – 2014 ($ MILLION)
TABLE 96 GLOBAL GELS WOUND CARE BIOMATERIAL MARKET, BY GEOGRAPHY2007 – 2014 ($ MILLION)
TABLE 97 GLOBAL SKIN SUBSTITUTE WOUND CARE BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 98 GLOBAL GASTROINTESTINAL BIOMATERIAL MARKET, BY GEOGRAPHY2007 – 2014 ($ MILLION)
TABLE 99 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 100 GLOBAL UROLOGICAL BIOMATERIAL DEVICE MARKET, BY TYPES2007 – 2014 ($ MILLION)
TABLE 101 GLOBAL UROLOGICAL BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014($ MILLION)
TABLE 102 GLOBAL UROLOGICAL BIOMATERIAL MARKET, BY GEOGRAPHY2007 – 2014 ($ MILLION)
TABLE 103 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS 116
TABLE 104 GLOBAL STENTS UROLOGICAL BIOMATERIAL MARKET, BY GEOGRAPHY2007 – 2014 ($ MILLION)
TABLE 105 GLOBAL CATHETER UROLOGICAL BIOMATERIAL MARKET, BY PRODUCTS2007 – 2014 ($ MILLION)
TABLE 106 GLOBAL CATHETERS UROLOGICAL BIOMATERIAL MARKET, BY GEOGRAPHY2007 – 2014 ($ MILLION)
TABLE 107 GLOBAL DIALYSIS CATHETER UROLOGICAL BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 108 GLOBAL DIALYSIS CATHETER UROLOGICAL BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 109 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 110 GLOBAL HEMODIALYSIS CATHETER UROLOGICAL BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 111 GLOBAL PERITONIAL CATHETER UROLOGICAL BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 112 GLOBAL URINARY CATHETER UROLOGICAL BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 113 GLOBAL URINARY CATHETERS UROLOGICAL BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 114 GLOBAL INDWELLING CATHETER UROLOGICAL BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 115 GLOBAL PLASTIC SURGERY BIOMATERIAL DEVICE MARKET, BY TYPES2007 – 2014 ($ MILLION)
TABLE 116 GLOBAL PLASTIC SURGERY BIOMATERIAL MARKET, BY PRODUCTS2007 – 2014 ($ MILLION)
TABLE 117 GLOBAL PLASTIC SURGERY BIOMATERIAL MARKET, BY GEOGRAPHY2007 – 2014 ($ MILLION)
TABLE 118 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 119 GLOBAL BREAST IMPLANTS PLASTIC SURGERY BIOMATERIAL DEVICE MARKET BY TYPES 2007 – 2014 ($ MILLION)
TABLE 120 GLOBAL BREAST IMPLANTS PLASTIC SURGERY BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 121 GLOBAL BREAST IMPLANTS PLASTIC SURGERY BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 122 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 123 GLOBAL SALINE-FILLED BREAST IMPLANT BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 124 GLOBAL SILICONE-GEL BREAST IMPLANT BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 125 GLOBAL INJECTABLE FILLERS BREAST IMPLANT BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 126 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 127 GLOBAL FACIAL IMPLANTS PLASTIC SURGERY BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 128 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 129 GLOBAL BIOMATERIAL MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 130 GLOBAL BIOMATERIAL CERAMICS MARKET, BY TYPES 2007 – 2014($ MILLION)
TABLE 131 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 132 TECHNOLOGICAL ADVANCEMENTS IN CERAMICS MARKET
TABLE 133 GLOBAL BIOINERT CERAMICS MARKET, BY TYPES OF BIOMATERIALS2007 – 2014 ($ MILLION)
TABLE 134 GLOBAL BIOACTIVE CERAMICS MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 135 GLOBAL BIODEGRADABLE CERAMICS MARKET, BY TYPES 2007 – 2014($ MILLION)
TABLE 136 GLOBAL METALLIC BIOMATERIAL MARKET, BY TYPES 2007 – 2014($ MILLION)
TABLE 137 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 138 GLOBAL PURE FORM METALS MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 139 GLOBAL ALLOY BIOMATERIAL MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 140 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 141 GLOBAL POLYMER BIOMATERIALS MARKET, BY TYPES 2007 – 2014($ MILLION)
TABLE 142 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 143 GLOBAL NATURAL POLYMER BIOMATERIAL MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 144 GLOBAL SYNTHETIC POLYMER BIOMATERIAL MARKET, BY TYPES OF BIOMATERIALS 2007 – 2014 ($ MILLION)
TABLE 145 APPLICATION MARKET FOR BIOMATERIALS
TABLE 146 GLOBAL BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 147 U.S. BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 148 EUROPEAN BIOMATERIAL MARKET, BY PRODUCTS,2007 – 2014 ($ MILLION)
TABLE 149 ASIAN BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 150 3DM, INC. PRODUCT PROFILE
TABLE 151 3DM, INC. STRATEGY
TABLE 152 ADVANSOURCE BIOMATERIALS CORPORATION PRODUCT PROFILE
TABLE 153 ALLERGAN INC. PRODUCT PROFILE
TABLE 154 ALLOSOURCE PRODUCT PROFILE
TABLE 155 ALLOSOURCE STRATEGY
TABLE 156 ALPHATEC SPINE, INC. PRODUCT PROFILE
TABLE 157 ALPHATEC SPINE, INC. STRATEGIES AND DEVELOPMENTS
TABLE 158 AMEDICA CORPORATION PRODUCT PROFILE
TABLE 159 AMEDICA CORPORATION DEVELOPMENTS
TABLE 160 ANGIOTECH PHARMACEUTICALS, INC. PRODUCT PROFILE
TABLE 161 NGIOTECH PHARMACEUTICALS, INC. STRATEGY
TABLE 162 APATECH LTD. PRODUCT PROFILE
TABLE 163 ARTIMPLANT AB PRODUCT PROFILE
TABLE 164 ARTIMPLANT AB STRATEGIES AND DEVELOPMENTS
TABLE 165 BIOINTERACTIONS LTD. PRODUCT PROFILE
TABLE 166 BIORETEC LTD. PRODUCT PROFILE
TABLE 167 BIO SYNTECH CANADA INC. PRODUCT PROFILE
TABLE 168 BIO SYNTECH CANADA INC. STRATEGY
TABLE 169 BOSTON SCIENTIFIC CORPORATION PRODUCT PROFILE
TABLE 170 COLLAGEN MATRIX, INC. PRODUCT PROFILE
TABLE 171 COLLAGEN MATRIX, INC. STRATEGY
TABLE 172 CORIN GROUP, PLC. PRODUCT PROFILE
TABLE 173 COVALON TECHNOLOGIES PRODUCT PROFILE
TABLE 174 COVALON STRATEGY
TABLE 175 CRYOLIFE INC, PRODUCT PROFILE
TABLE 176 CRYOLIFE INC., STRATEGY
TABLE 177 DAVOL, INC. PRODUCT PROFILE
TABLE 178 DAVOL, INC. STRATEGY
TABLE 179 DEPUY ORTHOPEDICS, INC. PRODUCT PROFILE
TABLE 180 DEPUY ORTHOPEDICS, INC. STRATEGY
TABLE 181 ETEX CORPORATION PRODUCT PROFILE
TABLE 182 ETEX CORPORATION STRATEGIES AND DEVELOPMENTS
TABLE 183 GENZYME BIOSURGERY PRODUCT PROFILE
TABLE 184 GENZYME BIOSURGERY DEVELOPMENTS
TABLE 185 INION OY PRODUCT PROFILE
TABLE 186 INTEGRA LIFE SCIENCES HOLDINGS CORP. PRODUCT PROFILE
TABLE 187 INTEGRA LIFE SCIENCES HOLDINGS CORP. STRATEGY
TABLE 188 INTERNATIONAL BIOCOMPOSITES LTD. PRODUCT PROFILE
TABLE 189 INTERNATIONAL BIOCOMPOSITES LTD. DEVELOPMENTS
TABLE 190 INVIBIO LTD. PRODUCT PROFILE
TABLE 191 INVIBIO LTD. STRATEGY
TABLE 192 ISTO TECHNOLOGIES, INC. APPLICATIONS
TABLE 192 KENSEY NASH CORPORATION PRODUCT PROFILE
TABLE 193 MEDTRONIC INC. PRODUCT PROFILE
TABLE 194 MEDTRONIC INC. STRATEGIES & DEVELOPMENTS
TABLE 195 MENTOR CORPORATION PRODUCT PROFILE
TABLE 196 MIV THERAPEUTICS INC. PRODUCT PROFILE
TABLE 197 OLYMPUS TERUMO PRODUCT PROFILE
TABLE 198 OLYMPUS TERUMO STRATEGY
TABLE 199 ORGANOGENESIS, INC. PRODUCT PROFILE
TABLE 200 ORTHOVITA PRODUCT PROFILE
TABLE 201 OSTEOTECH, INC. PRODUCT PROFILE
TABLE 202 PIONEER SURGICAL TECHNOLOGY PRODUCT PROFILE
TABLE 202 PIONEER SURGICAL TECHNOLOGY STRATEGY
TABLE 203 POLYMER TECHNOLOGY GROUP PROFILE
TABLE 204 PROTEIN POLYMER TECHNOLOGIES, INC. PRODUCT PROFILE
TABLE 205 RTI BIOLOGICS PRODUCT PROFILE
TABLE 206 RTI BIOLOGICS STRATEGIES
TABLE 207 SMITH & NEPHEW PLC PRODUCT PROFILE
TABLE 208 SMITH & NEPHEW PLC STRATEGY
TABLE 209 STRYKER CORPORATION PRODUCT PROFILE
TABLE 210 SYNTHES INC. PRODUCT PROFILE
TABLE 211 SYNTHES INC. STRATEGY
TABLE 212 TEI BIOSCIENCES PRODUCT PROFILE
TABLE 213 TORNIER INC. PRODUCT PROFILE
TABLE 214 TORNIER INC. STRATEGY
TABLE 215 VYGON S.A PRODUCT PROFILE
TABLE 216 VYGON S.A STRATEGY
TABLE 217 W.L. GORE & ASSOCIATES INC. PRODUCT PROFILE
TABLE 218 WRIGHT MEDICAL GROUP, INC. PRODUCT PROFILE
TABLE 219 WRIGHT MEDICAL GROUP, INC. DEVELOPMENTS
TABLE 220 ZIMMER HOLDINGS, INC. PRODUCT PROFILE
TABLE 221 ZIMMER HOLDINGS, INC. STRATEGY
LIST OF FIGURES
FIGURE 1 EVOLUTION OF BIOMATERIALS
FIGURE 2 PARENTAL STRUCTURE OF BIOMATERIALS
FIGURE 3 CHARACTERISTICS OF BIOMATERIAL SCIENCE
FIGURE 4 FACTORS AFFECTING THE BIOMATERIAL MARKET
FIGURE 5 GLOBAL BIOMATERIAL DEVICE MARKET, BY PRODUCTS (2009)
FIGURE 6 RELATIVE POTENTIAL MATRIX FOR BIOMATERIAL PRODUCTS MARKET (2014)
FIGURE 7 INCREASING DISABILITY WITH AGE
FIGURE 8 INCREASING AGING POPULATION
FIGURE 9 GEOGRAPHICAL ANALYSIS OF BIOMATERIAL MARKET (2009)
FIGURE 10 BIOMATERIALS PATENTS, BY GEOGRAPHY
FIGURE 11 PATENT TRENDS
LIST OF ACRONYMS AND ABBREVIATIONS
AAOS: American Academy of Orthopedic Surgery
AF: Atrial Fibrillation
BMP: Bone Morphogenic Protein
BTB: Bone Tendon Bone
CAGR: Compounded Annual Growth Rate
CE: Conformitй Europйene
CP: Combination Pharmacotherapy
CMF: Craniomaxillofacial
CRT: Cardiac Resynchronization Therapy
CSC: Cancellous Structure Ceramics
CT: Computed Tomography
DBM: Demineralized Bone Matrix
DES: Drug Eluting Stents
ESC: Environmental Stress Cracking
FDA: Food and Drugs Administration
HA: Hyaluronic Acid
ICD: Implantable Cardioverter Defibrillator
IDE: Investigational Device Exemption
LCP: Locking Compression Plate
MI: Myocardial Infraction
MRI: Magnetic Resonance Imaging
MIS: Minimally Invasive Surgery
MS: Multiple Sclerosis
OTC: Over the Counter
PEEK: Polyetheretherketone
PICC: Peripherally Inserted Central Catheter
PMMA: Polymethylmethacrylate
R&D: Research and Development
RF: Radio Frequency
ROW: Rest of the World
SFDA: State Food and Drugs Administration
FIGURE 1 EVOLUTION OF BIOMATERIALS
FIGURE 2 PARENTAL STRUCTURE OF BIOMATERIALS
FIGURE 3 CHARACTERISTICS OF BIOMATERIAL SCIENCE
FIGURE 4 FACTORS AFFECTING THE BIOMATERIAL MARKET
FIGURE 5 GLOBAL BIOMATERIAL DEVICE MARKET, BY PRODUCTS (2009)
FIGURE 6 RELATIVE POTENTIAL MATRIX FOR BIOMATERIAL PRODUCTS MARKET (2014)
FIGURE 7 INCREASING DISABILITY WITH AGE
FIGURE 8 INCREASING AGING POPULATION
FIGURE 9 GEOGRAPHICAL ANALYSIS OF BIOMATERIAL MARKET (2009)
FIGURE 10 BIOMATERIALS PATENTS, BY GEOGRAPHY
FIGURE 11 PATENT TRENDS
LIST OF ACRONYMS AND ABBREVIATIONS
AAOS: American Academy of Orthopedic Surgery
AF: Atrial Fibrillation
BMP: Bone Morphogenic Protein
BTB: Bone Tendon Bone
CAGR: Compounded Annual Growth Rate
CE: Conformitй Europйene
CP: Combination Pharmacotherapy
CMF: Craniomaxillofacial
CRT: Cardiac Resynchronization Therapy
CSC: Cancellous Structure Ceramics
CT: Computed Tomography
DBM: Demineralized Bone Matrix
DES: Drug Eluting Stents
ESC: Environmental Stress Cracking
FDA: Food and Drugs Administration
HA: Hyaluronic Acid
ICD: Implantable Cardioverter Defibrillator
IDE: Investigational Device Exemption
LCP: Locking Compression Plate
MI: Myocardial Infraction
MRI: Magnetic Resonance Imaging
MIS: Minimally Invasive Surgery
MS: Multiple Sclerosis
OTC: Over the Counter
PEEK: Polyetheretherketone
PICC: Peripherally Inserted Central Catheter
PMMA: Polymethylmethacrylate
R&D: Research and Development
RF: Radio Frequency
ROW: Rest of the World
SFDA: State Food and Drugs Administration
